ESPR Esperion Therapeutics, Inc.: institutional ownership and insider trading
1 funds reported holding $5.57M of Esperion Therapeutics, Inc. in their latest 13F filings; in Q2 2026 funds net bought $5.57M, with 1 new positions and 0 funds selling out; over the last 12 months insiders bought $0 and sold $576K on the open market.
Largest institutional holders of ESPR
- METEORA CAPITAL, LLC — $5.57M
Recent ESPR insider trades
- Jun 17, 2026: Halladay Benjamin sold 10,773 shares ($34.0K)
- Jun 17, 2026: Koenig Sheldon L. sold 53,588 shares ($169K)
- Jun 17, 2026: Looker Benjamin sold 11,824 shares ($37.4K)
- Mar 17, 2026: Halladay Benjamin sold 6,424 shares ($17.4K)
5%+ owners
- Glazer Capital, LLC: 8.2% (Schedule 13G, filed Jun 8, 2026)
- THE GOLDMAN SACHS GROUP, INC.: 6.7% (Schedule 13G, filed Aug 13, 2026)
- Vanguard Capital Management: 5.1% (Schedule 13G, filed Jul 31, 2026)